In summary, SS-a promotes the apoptosis of gastric cancer (GC) cells and suppresses their proliferation by inhibiting the PI3K-AKT signaling pathway and regulating the levels of Bax and Bcl-2 proteins. Here, BAX is linked to gastric cancer.